ReviewCurrent issues in molecular biology2026
Triple-Negative Breast Cancer: Molecular Subtypes; Immune Escape; Limitations of Current Immunotherapy; and the BTLA/HVEM/CD160 Axis as an Emerging Target.
Bernardo L Rapoport et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.